Imara, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public, Subsidiary
- Established
- 2015-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.imaratx.com
Clinical Trials
16
Active:11
Completed:2
Trial Phases
2 Phases
Phase 1:10
Phase 2:6
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (16 trials with phase data)• Click on a phase to view related trials
Phase 1
10 (62.5%)Phase 2
6 (37.5%)An Extension Study of IMR-687 in Adult Patients With Sickle Cell Anemia
- First Posted Date
- 2019-08-13
- Last Posted Date
- 2022-03-04
- Lead Sponsor
- Imara, Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT04053803
- Locations
- 🇺🇸
University of Connecticut Health Center, Farmington, Connecticut, United States
🇺🇸Foundation for Sickle Cell Disease Research, Hollywood, Florida, United States
🇺🇸Baylor Scott & White Medical Center - Temple, Temple, Texas, United States
News
No news found